Instil Bio, Inc. (TIL)

Instil Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	-	-	-	0.14
Gross Profit	-	-	-	-	0.14
Selling, General & Admin	46.33	50.91	69.34	51.31	13.48
Research & Development	13.63	39.63	136.83	103.96	18.47
Operating Expenses	59.96	90.54	206.17	155.27	31.95
Operating Income	-59.96	-90.54	-206.17	-155.27	-31.82
Interest Expense	-8.99	-5.21	-1.88	-	-
Interest & Investment Income	6.99	8.87	3.66	0.08	-
Other Non Operating Income (Expenses)	1.41	-0.58	-0.56	-1.28	-3.94
EBT Excluding Unusual Items	-60.55	-87.46	-204.96	-156.46	-35.76
Merger & Restructuring Charges	-7.49	-72.01	-5.43	-	-0.9
Impairment of Goodwill	-	-	-5.7	-	-
Asset Writedown	-	-	-1.93	-	-
Other Unusual Items	3.91	3.38	2.88	-0.29	-0.93
Pretax Income	-74.14	-156.09	-225.25	-156.76	-37.59
Income Tax Expense	-	-	-2.07	0.04	0.15
Net Income	-74.14	-156.09	-223.18	-156.79	-37.74
Net Income to Common	-74.14	-156.09	-223.18	-156.79	-37.74
Shares Outstanding (Basic)	7	7	6	5	1
Shares Outstanding (Diluted)	7	7	6	5	1
Shares Change (YoY)	0.10%	0.44%	22.19%	562.55%	62.05%
EPS (Basic)	-11.39	-24.00	-34.46	-29.59	-47.18
EPS (Diluted)	-11.39	-24.00	-34.46	-29.59	-47.18
Free Cash Flow	-55.7	-102.69	-264.75	-179.97	-80.43
Free Cash Flow Per Share	-8.55	-15.79	-40.88	-33.96	-100.55
Gross Margin	-	-	-	-	100.00%
Operating Margin	-	-	-	-	-23055.07%
Profit Margin	-	-	-	-	-27346.38%
Free Cash Flow Margin	-	-	-	-	-58284.06%
EBITDA	-56.35	-85.79	-200.18	-152.51	-31.56
D&A For EBITDA	3.61	4.76	5.99	2.75	0.26
EBIT	-59.96	-90.54	-206.17	-155.27	-31.82

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q